Northern Trust Corp Vivos Therapeutics, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.83 - $21.25 $9,222 - $236,108	-11,111 Reduced 27.26%	29,655 $19,000
Q1 2022 May 13, 2022	BUY	$1.63 - $3.63 $264 - $588	162 Added 0.4%	40,766 $109,000
Q4 2021 Feb 08, 2022	SELL	$2.25 - $4.11 $951 - $1,738	-423 Reduced 1.03%	40,604 $91,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $80,064 - $174,309	29,544 Added 257.28%	41,027 $166,000
Q2 2021 Aug 13, 2021	BUY	$4.83 - $9.67 $55,462 - $111,040	11,483 New	11,483 $57,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.